Skip to main content
logo
Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.400
+0.070 (3.00%)
At close: Apr 17, 2026, 4:00 PM EDT
2.381
-0.019 (-0.80%)
After-hours: Apr 17, 2026, 7:54 PM EDT

Palisade Bio Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
401.81M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023250.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Niagen Bioscience129.42M
Enanta Pharmaceuticals66.98M
X4 Pharmaceuticals35.11M
Opus Genetics14.20M
Ovid Therapeutics7.25M
Armata Pharmaceuticals4.90M
Avalo Therapeutics59.00K
Revenue Rankings

PALI News

More News